
After hopeful early signs, study of popular heartburn drug shows mixed results against Covid-19
CNN
At one point at the beginning of the pandemic, there was hope that a popular and inexpensive over-the-counter heartburn drug might hold promise for treating Covid-19, but a newly published study shows mixed results.
In the clinical trial, people with mild to moderate Covid-19 who took very high doses of famotidine, the active ingredient in Pepcid, had some improvement in their symptoms more quickly than those who took a placebo, a pill that does nothing.
But the trial, believed to be the first of its kind, was small, and the effect was far from dramatic. Among the 55 study participants, those who were assigned to take famotidine had an estimated 50% reduction in symptoms at 8.2 days, and those who were assigned a placebo saw that reduction in 11.4 days.

More than two weeks after the stunning US raid on Caracas that led to the capture of Nicolás Maduro, the political confrontation over the future of Venezuela is rapidly coalescing around two leaders, both women, who represent different visions for their country: the acting president, Delcy Rodríguez, who stands for continuity, and opposition leader María Corina Machado, who seeks the restoration of democracy.

President Trump says he can pull funding for sanctuary cities. Judges have repeatedly said otherwise
Trump’s threat is a broader version of one his administration has made many times already, attempting to cut funding to local governments it declared as “sanctuary jurisdictions,” but those efforts have been stopped repeatedly by judges.











